| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | -5.5% |
| Cost of Revenue | $652K | +6.5% |
| Gross Profit | $619K | -15.6% |
| R&D Expense | $3.7M | -3.1% |
| SG&A Expense | $4.4M | -34.7% |
| Operating Income | -$7.4M | +24.0% |
| Interest Expense | $5K | +0.0% |
| Pre-tax Income | -$7.1M | +45.2% |
| Income Tax | $0 |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $405K | -66.2% |
| Accounts Receivable | $34K | -12.8% |
| Inventory | $1.4M | -11.7% |
| Current Assets | $2.9M | -21.8% |
| Total Assets | $8.7M | -11.7% |
| Current Liabilities | $2.3M | -3.5% |
| Long-term Debt | $134K | -2.2% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.8M | +7.8% |
| Capital Expenditures | $112K | -18.8% |
| Investing Cash Flow | -$442K | -39.4% |
| Financing Cash Flow | $4.5M | +26.3% |
| Free Cash Flow | -$4.9M | +8.1% |
| — |
| Net Income | -$7.1M | +45.2% |
| EPS (Basic) | -$0.09 | +59.1% |
| EPS (Diluted) | -$0.09 | +59.1% |
| Total Liabilities |
| $2.4M |
| -6.4% |
| Stockholders' Equity | $6.3M | -13.5% |